//
sign in
Profile
by @danabra.mov
Profile
by @dansshadow.bsky.social
Profile
by @jimpick.com
AviHandle
by @danabra.mov
AviHandle
by @dansshadow.bsky.social
AviHandle
by @katherine.computer
EventsList
by @katherine.computer
ProfileHeader
by @dansshadow.bsky.social
ProfileHeader
by @danabra.mov
ProfileMedia
by @danabra.mov
ProfilePlays
by @danabra.mov
ProfilePosts
by @danabra.mov
ProfilePosts
by @dansshadow.bsky.social
ProfileReplies
by @danabra.mov
Record
by @atsui.org
Skircle
by @danabra.mov
StreamPlacePlaylist
by @katherine.computer
+ new component
ProfilePosts









Loading...
5 year follow-up from the PROVIDE trial suggests that additional parenteral AA (1 g/d for 5 days) in ELBW infants does not improve school-age neurocognitive outcomes, and may have potential adverse effects on muscle strength and psychosocial function: buff.ly/cwQ0idh #EBNEOalerts #neoEBM #neosky
1d
Even without bradycardia, oxygen desaturations in very preterm infants are linked to significant cerebral and abdominal hypoxemia. karger.com/neo/article/12… #EBNEOalerts #neoEBM #neosky
3d
Evidence-based Neonatology
Evidence-based Neonatology
Start reviewing the programme and planning your trip. Don't miss the cutting edge science! #neoEBM #neosky
1mo
Evidence-based Neonatology
Could dexamethasone drops prevent progression of ROP? Swedish population cohort study explores this: aaojournal.org/article/S0161-… #neoEBM #EBNEOalerts #neosky
19d
3d
Mitra et al. conducted a comparative effectiveness research study to compare the relative effectiveness of different PDA regimens and to compare the clinical outcomes between infants treated with pharmacotherapy and those not treated. buff.ly/JEZiU5U #EBNeoAlerts #NeoEBM #neosky
3-year interim analysis of the FIREFLEYE next trial demonstrates that aflibercept provides stable control for ROP and comparable safety to laser therapy buff.ly/syYWEED #EBNEOalerts #neoEBM #neosky
11d
Evidence-based Neonatology
Evidence-based Neonatology
Martinez et al. conducted a post-hoc exploratory analysis of PLUSS to describe the early respiratory trajectories of infants born <26 weeks’ gestation who received surfactant during their initial NICU admission. buff.ly/Hk697aO #EBNeoAlerts #NeoEBM #neosky
The @ebneo.bsky.social 2025 Impact Article of the Year race is down to the final two! After a high-stakes first round, these 2 RCTs have emerged as the frontrunners: Faix et al. Laughon et al. Vote now to crown the winner! 🗳️ ⏳ Open for 5 days only! buff.ly/XvU87C4 #neosky #neoEBM
‼️ Abstract Deadline Extended‼️ Think you missed the deadline yesterday? Don't fret! New deadline April 15th! Get your abstracts submitted and join @EBNEO in Lyon, France for #CEPAS2026 in October. Submit now: buff.ly/ANz6BNi #neosky #neoEBM @espr-esn.bsky.social
Siefkes et al Vs Mitra et al Which publication posted by @ebneo.bsky.social during May is most likely to impact your practice? IAOTM Vote is now open on our website! ebneo.org/vote #EBNeoPolls #neoSky #neoEBM
The interactive scientific programme of our 2026 international meeting @cepascongress.bsky.social together with EAP & in collab. with GFCNI is live. Explore session details, confirmed talks & speakers! Kindly supported by @99nicu.bsky.social & @ebneo.bsky.social. More: www.cepas.org/scientific-p...
Evidence-based Neonatology
14d
2mo
15d
2mo
1mo
Which Publication Will Be Crowned the 2025 EBNEO Impact Article of the Year? After a highly competitive first round involving eight outstanding articles, two finalists have risen to the top. While the...
buff.ly
Article of the Year - Evidence-Based Neonatology
Evidence-based Neonatology
Evidence-based Neonatology
Evidence-based Neonatology
Evidence-based Neonatology
European Society for Paediatric Research (ESPR)